ANKRD9
Basic information
Region (hg38): 14:102501767-102509799
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ANKRD9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 31 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 0 | 0 |
Variants in ANKRD9
This is a list of pathogenic ClinVar variants found in the ANKRD9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-102506953-G-C | not specified | Uncertain significance (Dec 06, 2023) | ||
14-102507025-C-T | not specified | Uncertain significance (Jul 05, 2023) | ||
14-102507042-A-G | not specified | Uncertain significance (Jun 13, 2023) | ||
14-102507120-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
14-102507211-G-A | not specified | Uncertain significance (Jun 22, 2021) | ||
14-102507213-T-C | not specified | Uncertain significance (May 02, 2023) | ||
14-102507226-C-A | not specified | Uncertain significance (Jun 07, 2023) | ||
14-102507250-C-T | not specified | Uncertain significance (Jun 05, 2023) | ||
14-102507256-A-G | not specified | Uncertain significance (Oct 04, 2022) | ||
14-102507304-G-A | not specified | Uncertain significance (Apr 20, 2024) | ||
14-102507309-G-A | not specified | Uncertain significance (Dec 02, 2022) | ||
14-102507382-C-T | not specified | Uncertain significance (May 17, 2023) | ||
14-102507402-A-G | not specified | Uncertain significance (Jul 06, 2021) | ||
14-102507426-C-A | not specified | Uncertain significance (May 01, 2022) | ||
14-102507486-G-T | not specified | Uncertain significance (Feb 16, 2023) | ||
14-102507499-G-A | not specified | Uncertain significance (Oct 12, 2021) | ||
14-102507501-C-A | not specified | Uncertain significance (Dec 12, 2023) | ||
14-102507502-G-C | not specified | Uncertain significance (May 09, 2023) | ||
14-102507504-A-C | not specified | Uncertain significance (May 09, 2022) | ||
14-102507517-G-A | not specified | Uncertain significance (Mar 24, 2023) | ||
14-102507558-G-A | not specified | Uncertain significance (Dec 19, 2023) | ||
14-102507574-C-T | not specified | Uncertain significance (Apr 19, 2023) | ||
14-102507577-C-G | not specified | Uncertain significance (Sep 01, 2021) | ||
14-102507610-T-C | not specified | Uncertain significance (Aug 01, 2022) | ||
14-102507699-C-T | not specified | Uncertain significance (Mar 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ANKRD9 | protein_coding | protein_coding | ENST00000286918 | 1 | 2958 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.294 | 0.633 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.90 | 64 | 123 | 0.519 | 0.0000109 | 1876 |
Missense in Polyphen | 25 | 45.676 | 0.54733 | 717 | ||
Synonymous | 2.21 | 43 | 65.8 | 0.653 | 0.00000629 | 758 |
Loss of Function | 1.36 | 1 | 3.91 | 0.256 | 1.70e-7 | 67 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- Post-translational protein modification;Metabolism of proteins;Neddylation
(Consensus)
Haploinsufficiency Scores
- pHI
- 0.179
- hipred
- N
- hipred_score
- 0.354
- ghis
- 0.663
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.257
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ankrd9
- Phenotype
- immune system phenotype; skeleton phenotype; hematopoietic system phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- post-translational protein modification;protein localization to plasma membrane
- Cellular component
- cytosol;membrane;axon initial segment
- Molecular function
- ion channel binding